PerkinElmer has enhanced its Opera High Content Screening (HCS) System by adding new hardware and software features.
The enhancements will facilitate academic researchers and biopharmaceutical to perform improved live cell imaging assays for efficient drug discovery and life science research workflow.
The new features in Opera system’s Acapella High Content Imaging and Analysis Software includes assay-centric building blocks which increase productivity through an intuitive software interface.
The Opera system’s new transmitted light module with digital phase-contrast aids users to image and segment cells that have not been labeled fluorescently.
The light module feature is useful for live cell applications as it eliminates the need to label cells, thus diminishing potential labeling artifacts, cell damage, assay costs and time.
PerkinElmer high content instruments and applications director Jacob Tesdorpf said now end-users can perform even the most challenging imaging assay applications with live cells, for more scientifically- and drug discovery-relevant applications.